• Home
  • News
  • Calendar
  • About DF/HCC
  • Membership
  • Visitor Center

Nadine Jackson McCleary, MD, MPH

Publications

  • Stanworth SJ, Estcourt LJ, Powter G, Kahan BC, Dyer C, Choo L, Bakrania L, Llewelyn C, Littlewood T, Soutar R, Norfolk D, Copplestone A, Smith N, Kerr P, Jones G, Raj K, Westerman DA, Szer J, Jackson N, Bardy PG, Plews D, Lyons S, Bielby L, Wood EM, Murphy MF, .A no-prophylaxis platelet-transfusion strategy for hematologic cancers.N Engl J Med. 2013 May 9;368(19):1771-80.
    23656642
  • Chan JA, Mayer RJ, Jackson N, Malinowski P, Regan E, Kulke MH.Phase I study of sorafenib in combination with everolimus (RAD001) in patients with advanced neuroendocrine tumors.Cancer Chemother Pharmacol. 2013 Mar 9.
    23475104
  • McCleary NJ.Treatment considerations in elderly colorectal cancer patients.Clin Adv Hematol Oncol. 2010 May;8(5):337-9.
    20551893
  • McCleary NJ, Meyerhardt JA.New developments in the adjuvant therapy of stage II colon cancer. Risk assessments in the older patient.Oncology (Huntingt). 2010 Jan;24(1 Suppl 1):3-8.
    20225605
  • McCleary NJ, Niedzwiecki D, Hollis D, Saltz LB, Schaefer P, Whittom R, Hantel A, Benson A, Goldberg R, Meyerhardt JA.Impact of smoking on patients with stage III colon cancer: results from Cancer and Leukemia Group B 89803.Cancer. 2010 Feb 15;116(4):957-66.
    20052723
  • Jackson NA, Barrueco J, Soufi-Mahjoubi R, Marshall J, Mitchell E, Zhang X, Meyerhardt J.Comparing safety and efficacy of first-line irinotecan/fluoropyrimidine combinations in elderly versus nonelderly patients with metastatic colorectal cancer: findings from the bolus, infusional, or capecitabine with camptostar-celecoxib study.Cancer. 2009 Jun 15;115(12):2617-29.
    19382200